Yamin ‘Mo’ Khan appointed Chief Executive Officer of Open Orphan
LONDON, UK: Open Orphan plc, a rapidly growing contract research company that is a world leader in testing vaccines and antivirals using human challenge clinical...
Data shows SARS-CoV-2 human challenge studies safe in healthy young adults
Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge...
Open Orphan receives Court approval for capital reduction
LONDON: Open Orphan has received Court approval for the reduction in capital. The reduction of capital will become effective on registration of the Court order...
Open Orphan signs contract with UK government to develop COVID-19 human challenge study model
LONDON: Open Orphan plc (ORPH) announced the signing of a contract by hVIVO, a subsidiary of Open Orphan, with the UK Government to develop a...
Open Orphan gets £4.3 million challenge study contract win with global vaccine company
LONDON: Open Orphan plc (ORPH), announced a new £4.3 million contract to conduct a human viral challenge study utilising one of its 8 traditional challenge...